P&K Skin Research Center Past Earnings Performance
Past criteria checks 1/6
P&K Skin Research Center's earnings have been declining at an average annual rate of -32.5%, while the Life Sciences industry saw earnings growing at 21.2% annually. Revenues have been declining at an average rate of 17.3% per year. P&K Skin Research Center's return on equity is 6.3%, and it has net margins of 32.4%.
Key information
-32.5%
Earnings growth rate
-32.9%
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | -17.3% |
| Return on equity | 6.3% |
| Net Margin | 32.4% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How P&K Skin Research Center makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 14,843 | 4,813 | 3,998 | 1,357 |
| 30 Sep 23 | 15,766 | 5,323 | 3,972 | 1,508 |
| 30 Jun 23 | 16,602 | 6,080 | 3,805 | 1,636 |
| 31 Mar 23 | 17,740 | 7,170 | 3,590 | 1,675 |
| 31 Dec 22 | 17,957 | 7,130 | 3,476 | 1,670 |
Quality Earnings: A347740 has high quality earnings.
Growing Profit Margin: A347740's current net profit margins (32.4%) are lower than last year (39.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if A347740's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare A347740's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: A347740 had negative earnings growth (-32.5%) over the past year, making it difficult to compare to the Life Sciences industry average (7.5%).
Return on Equity
High ROE: A347740's Return on Equity (6.3%) is considered low.